1993
DOI: 10.1136/jnnp.56.3.245
|View full text |Cite
|
Sign up to set email alerts
|

Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

19
159
0
26

Year Published

1997
1997
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 265 publications
(208 citation statements)
references
References 32 publications
19
159
0
26
Order By: Relevance
“…"I Detrusor hyperreflexia is present in patients with multiple sclerosis with lower limb pyramidal involvement and has been attributed to interruption of pathways between the pons and the sacral cord. 20 …”
Section: Discussionmentioning
confidence: 99%
“…"I Detrusor hyperreflexia is present in patients with multiple sclerosis with lower limb pyramidal involvement and has been attributed to interruption of pathways between the pons and the sacral cord. 20 …”
Section: Discussionmentioning
confidence: 99%
“…Urinary symptomatology is polymorphic and, like its incidence, subject to change over time, but it tends to increase with disease progression and it is mainly the result of spinal cord involvement. The most frequent are storage symptoms (urinary frequency, urgency, and urge incontinence) while voiding symptoms (hesitancy, incomplete voiding and urinary retention) exist to a lesser degree [3]. Therapeutic options for storage symptoms vary and they include, with or without associated clean intermittent self-catheterization, conservative treatments such as anticholinergic drugs -although the published data provide limited evidence for their efficacy in MS [4,5].…”
Section: Introductionmentioning
confidence: 94%
“…The database created was analyzed for that period. The variables analyzed were age, gender, race, age of disease onset, type of evolution according to Lublin classification 4 , Expanded Disability Status Scale (EDSS) 15 , amount of years suffering the disease, treatment with interferons, glatiramer acetate or other medications and its side effects, Beck depression scale 16 , and urinary dysfunction symptoms through a questionnaire comprising fundamental questions regarding lower urinary tract symptoms 17 .…”
Section: Methodsmentioning
confidence: 99%